Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 76.07

+0.9%

Nov 12 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1713)	12/5/2006 3:56:54 PM
From: Jibacoa	Read Replies (1) of 3722

It seems that Tim Barabe & other insiders that have been consistently buying some shares of ARQL this Yr.were on the right tract.<g> The stock today continued on the upmove that started on Nov.10 from the 4.05 level & seems that will close near its intraday H. bigcharts.marketwatch.com That was in spite of the poor results on the 3rdQ, the expected loss of close to $1/shr this Yr. vs. the loss of $0.22/shr in 2005 & the expected loss of $1.55/shr in 2007.<g> But on Nov.9 was when it announced that ARQ 501 had good potential when used in combination with chemotherapy agents, as shown from he results of the P1b in which ARQ 501 was used in combination with docetaxel. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next